| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP,Clinical &Medical Affairs
1 company
Hogge Gary S. serves as a SVP,Clinical &Medical Affairs at LCTX. Across recent SEC filings that breaks down to 0 buys and 3 sells. Those positions are worth an estimated $14K at current prices.
The biggest single holding is LCTX (~$14K) as SVP,Clinical &Medical Affairs. The recent filings there lean toward selling, a net 539,283 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 29, 2021 | LCTX Lineage Cell Therapeutics, Inc. | SVP,Clinical &Medical Affairs | Sale+OE | 539,283 | $2.45 | $1,321,328.90 | -90.5% | -37.9% | -49.0% |